Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma.

van Hootegem SJM, Smithers BM, Gotley DC, Brosda S, Thomson IG, Thomas JM, Gartside M, van Lanschot JJB, Lagarde SM, Wijnhoven BPL, Barbour AP.

Ann Surg Oncol. 2019 Apr 2. doi: 10.1245/s10434-019-07322-x. [Epub ahead of print]

PMID:
30941657
2.

Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus.

Visser E, Edholm D, Smithers BM, Thomson IG, Burmeister BH, Walpole ET, Gotley DC, Joubert WL, Atkinson V, Mai T, Thomas JM, Barbour AP.

J Surg Oncol. 2018 Jun;117(8):1687-1696. doi: 10.1002/jso.25089. Epub 2018 May 28.

PMID:
29806960
3.

Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy.

Thomson IG, Wallen MP, Hall A, Ferris R, Gotley DC, Barbour AP, Lee A, Thomas J, Smithers BM.

Int J Surg. 2018 May;53:86-92. doi: 10.1016/j.ijsu.2018.03.030. Epub 2018 Mar 16.

PMID:
29555526
4.

Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open Surgery.

Barbour AP, Cormack OMM, Baker PJ, Hirst J, Krause L, Brosda S, Thomas JM, Blazeby JM, Thomson IG, Gotley DC, Smithers BM.

Ann Surg. 2017 Jun;265(6):1158-1165. doi: 10.1097/SLA.0000000000001899.

PMID:
27429022
5.

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.

Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, GafĂ  R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, Zhang X, Ferracin M, Churchman M, van Galen JF, Beverloo BH, Shariati M, Haderk F, Estecio MR, Garcia-Manero G, Patijn GA, Gotley DC, Bhardwaj V, Shureiqi I, Sen S, Multani AS, Welsh J, Yamamoto K, Taniguchi I, Song MA, Gallinger S, Casey G, Thibodeau SN, Le Marchand L, Tiirikainen M, Mani SA, Zhang W, Davuluri RV, Mimori K, Mori M, Sieuwerts AM, Martens JW, Tomlinson I, Negrini M, Berindan-Neagoe I, Foekens JA, Hamilton SR, Lanza G, Kopetz S, Fodde R, Calin GA.

Genome Res. 2013 Sep;23(9):1446-61. doi: 10.1101/gr.152942.112. Epub 2013 Jun 24.

6.

Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes.

Thomson IG, Gotley DC, Barbour AP, Martin I, Jayasuria N, Thomas J, Smithers BM.

Gastric Cancer. 2014 Jan;17(1):152-60. doi: 10.1007/s10120-013-0240-3. Epub 2013 Mar 9.

PMID:
23474836
7.

Impact of postoperative morbidity on long-term survival after oesophagectomy.

Hii MW, Smithers BM, Gotley DC, Thomas JM, Thomson I, Martin I, Barbour AP.

Br J Surg. 2013 Jan;100(1):95-104. doi: 10.1002/bjs.8973. Epub 2012 Nov 12.

8.

Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.

Nancarrow DJ, Clouston AD, Smithers BM, Gotley DC, Drew PA, Watson DI, Tyagi S, Hayward NK, Whiteman DC; Australian Cancer Study; Study of Digestive Health.

PLoS One. 2011;6(7):e22513. doi: 10.1371/journal.pone.0022513. Epub 2011 Jul 28.

9.

Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy.

Hirst J, Smithers BM, Gotley DC, Thomas J, Barbour A.

Ann Surg Oncol. 2011 Jun;18(6):1766-74. doi: 10.1245/s10434-010-1508-z. Epub 2011 Jan 7.

PMID:
21213056
10.

Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer.

Zingg U, Smithers BM, Gotley DC, Smith G, Aly A, Clough A, Esterman AJ, Jamieson GG, Watson DI.

Ann Surg Oncol. 2011 May;18(5):1460-8. doi: 10.1245/s10434-010-1474-5. Epub 2010 Dec 24.

PMID:
21184193
11.

Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.

Burmeister BH, Thomas JM, Burmeister EA, Walpole ET, Harvey JA, Thomson DB, Barbour AP, Gotley DC, Smithers BM.

Eur J Cancer. 2011 Feb;47(3):354-60. doi: 10.1016/j.ejca.2010.09.009.

PMID:
21084184
12.

Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia.

Smithers BM, Fahey PP, Corish T, Gotley DC, Falk GL, Smith GS, Kiroff GK, Clouston AD, Watson DI, Whiteman DC.

Med J Aust. 2010 Nov 15;193(10):572-7.

PMID:
21077812
13.

Thoracoscopic-assisted esophagectomy for esophageal cancer: analysis of patterns and prognostic factors for recurrence.

Thomson IG, Smithers BM, Gotley DC, Martin I, Thomas JM, O'Rourke P, Barbour AP.

Ann Surg. 2010 Aug;252(2):281-91. doi: 10.1097/SLA.0b013e3181e909a2.

PMID:
20647926
14.

Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors.

Barbour AP, Jones M, Brown I, Gotley DC, Martin I, Thomas J, Clouston A, Smithers BM.

Ann Surg Oncol. 2010 Sep;17(9):2494-502. doi: 10.1245/s10434-010-1025-0. Epub 2010 Mar 27.

PMID:
20349213
15.

Laparoscopic upper gut surgery.

Gotley DC.

J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S15-9. doi: 10.1111/j.1440-1746.2009.06066.x. Review.

PMID:
19799692
16.

Prognostic value of maximum standardized uptake values from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery alone.

Shenfine J, Barbour AP, Wong D, Thomas J, Martin I, Gotley DC, Smithers BM.

Dis Esophagus. 2009;22(8):668-75. doi: 10.1111/j.1442-2050.2009.00941.x. Epub 2009 Feb 13.

PMID:
19222534
17.

Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.

Smith E, De Young NJ, Pavey SJ, Hayward NK, Nancarrow DJ, Whiteman DC, Smithers BM, Ruszkiewicz AR, Clouston AD, Gotley DC, Devitt PG, Jamieson GG, Drew PA.

Mol Cancer. 2008 Oct 2;7:75. doi: 10.1186/1476-4598-7-75.

18.

Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.

Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM.

Ann Surg Oncol. 2008 Oct;15(10):2894-902. doi: 10.1245/s10434-008-0084-y. Epub 2008 Jul 29.

PMID:
18663531
19.

Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays.

Nancarrow DJ, Handoko HY, Smithers BM, Gotley DC, Drew PA, Watson DI, Clouston AD, Hayward NK, Whiteman DC.

Cancer Res. 2008 Jun 1;68(11):4163-72. doi: 10.1158/0008-5472.CAN-07-6710.

20.

Consideration of mesh-related complications.

Shenfine J, Barbour A, Martin I, Smithers BM, Gotley DC.

Ann R Coll Surg Engl. 2008 Mar;90(2):175-6; author reply 176. doi: 10.1308/003588408X261780. No abstract available.

21.

Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus.

Smithers BM, Couper GC, Thomas JM, Wong D, Gotley DC, Martin I, Harvey JA, Thomson DB, Walpole ET, Watts N, Burmeister BH.

Dis Esophagus. 2008;21(2):151-8. doi: 10.1111/j.1442-2050.2007.00732.x.

PMID:
18269651
22.

Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy.

Smithers BM, Cullinan M, Thomas JM, Martin I, Barbour AP, Burmeister BH, Harvey JA, Thomson DB, Walpole ET, Gotley DC.

Dis Esophagus. 2007;20(6):471-7.

PMID:
17958721
23.

Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.

Whiteman DC, Sadeghi S, Pandeya N, Smithers BM, Gotley DC, Bain CJ, Webb PM, Green AC; Australian Cancer Study.

Gut. 2008 Feb;57(2):173-80. Epub 2007 Oct 11.

PMID:
17932103
24.

Comparison of the outcomes between open and minimally invasive esophagectomy.

Smithers BM, Gotley DC, Martin I, Thomas JM.

Ann Surg. 2007 Feb;245(2):232-40.

25.

Radiofrequency ablation of liver tumors: a systematic review.

Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ.

Arch Surg. 2006 Feb;141(2):181-90. Review.

PMID:
16490897
26.

Minimally invasive esophagectomy: short- and long-term outcomes.

Leibman S, Smithers BM, Gotley DC, Martin I, Thomas J.

Surg Endosc. 2006 Mar;20(3):428-33. Epub 2005 Dec 28.

PMID:
16391954
27.

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.

Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC, Whiteman DC.

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2481-6.

28.

Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin.

Burmeister BH, Walpole ET, Burmeister EA, Thomas J, Thomson DB, Harvey JA, Mark Smithers B, Gotley DC.

Int J Clin Oncol. 2005 Aug;10(4):256-61.

PMID:
16136371
29.

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW; Trans-Tasman Radiation Oncology Group; Australasian Gastro-Intestinal Trials Group.

Lancet Oncol. 2005 Sep;6(9):659-68.

PMID:
16129366
30.

Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery.

Byrne JP, Smithers BM, Nathanson LK, Martin I, Ong HS, Gotley DC.

Br J Surg. 2005 Aug;92(8):996-1001.

PMID:
15997449
31.

Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia.

Segara D, Biankin AV, Kench JG, Langusch CC, Dawson AC, Skalicky DA, Gotley DC, Coleman MJ, Sutherland RL, Henshall SM.

Clin Cancer Res. 2005 May 1;11(9):3587-96.

32.

Expression of the cell surface mucin gene family in adenocarcinomas.

Packer LM, Williams SJ, Callaghan S, Gotley DC, McGuckin MA.

Int J Oncol. 2004 Oct;25(4):1119-26.

PMID:
15375564
33.

Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia.

Harvey JA, Bessell JR, Beller E, Thomas J, Gotley DC, Burmeister BH, Walpole ET, Thomson DB, Martin I, Doyle L, Burmeister E, Smithers BM.

Dis Esophagus. 2004;17(3):260-5.

PMID:
15361102
34.

Current concepts of tumour metastasis.

Barbour A, Gotley DC.

Ann Acad Med Singapore. 2003 Mar;32(2):176-84. Review.

PMID:
12772520
35.

Tumor progression in hepatocellular carcinoma: relationship with tumor stroma and parenchymal disease.

Lockwood DS, Yeadon TM, Clouston AD, Crawford DG, Fawcett J, Callaghan SA, Gotley DC.

J Gastroenterol Hepatol. 2003 Jun;18(6):666-72.

PMID:
12753148
36.

Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis.

Aimes RT, Zijlstra A, Hooper JD, Ogbourne SM, Sit ML, Fuchs S, Gotley DC, Quigley JP, Antalis TM.

Thromb Haemost. 2003 Mar;89(3):561-72.

PMID:
12624642
37.

Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3.

Barbour AP, Reeder JA, Walsh MD, Fawcett J, Antalis TM, Gotley DC.

Cancer Res. 2003 Feb 15;63(4):887-92.

38.

Early reoperation for acute dysphagia following laparoscopic fundoplication.

Bessell JR, Adair WD, Smithers BM, Martin I, Menzies B, Gotley DC.

Br J Surg. 2002 Jun;89(6):783-6.

PMID:
12027992
39.

Human trypsinogen in colorectal cancer.

Williams SJ, Gotley DC, Antalis TM.

Int J Cancer. 2001 Jul 1;93(1):67-73.

40.

Thoracoscopic mobilization of the esophagus. A 6 year experience.

Smithers BM, Gotley DC, McEwan D, Martin I, Bessell J, Doyle L.

Surg Endosc. 2001 Feb;15(2):176-82.

PMID:
11285963
41.

Chronic dysphagia following laparoscopic fundoplication.

Bessell JR, Finch R, Gotley DC, Smithers BM, Nathanson L, Menzies B.

Br J Surg. 2000 Oct;87(10):1341-5.

PMID:
11044158
42.

Grantsmanship: achieving success in research funding.

Gotley DC.

Aust N Z J Surg. 2000 Apr;70(4):297-301.

PMID:
10779063
43.

Two novel mucin genes down-regulated in colorectal cancer identified by differential display.

Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM.

Cancer Res. 1999 Aug 15;59(16):4083-9.

44.

The MUC3 gene encodes a transmembrane mucin and is alternatively spliced.

Williams SJ, Munster DJ, Quin RJ, Gotley DC, McGuckin MA.

Biochem Biophys Res Commun. 1999 Jul 22;261(1):83-9.

PMID:
10405327
45.

Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.

Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM.

Cancer Res. 1998 Aug 15;58(16):3719-26.

46.

Down-regulation of the down-regulated in adenoma (DRA) gene correlates with colon tumor progression.

Antalis TM, Reeder JA, Gotley DC, Byeon MK, Walsh MD, Henderson KW, Papas TS, Schweinfest CW.

Clin Cancer Res. 1998 Aug;4(8):1857-63.

47.

Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma.

Hii SI, Nicol DL, Gotley DC, Thompson LC, Green MK, Jonsson JR.

Br J Cancer. 1998 Mar;77(6):880-3.

48.

Diffuse oesophageal spasm: diagnosis by ambulatory 24 hour manometry.

Barham CP, Gotley DC, Fowler A, Mills A, Alderson D.

Gut. 1997 Aug;41(2):151-5.

49.

Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma.

Ooi LP, Crawford DH, Gotley DC, Clouston AD, Strong RW, Gobe GC, Halliday JW, Bridle KR, Ramm GA.

J Hepatol. 1997 Apr;26(4):798-807.

PMID:
9126792
50.

Laparoscopic Nissen fundoplication and postoperative dysphagia-can it be predicted?

Gotley DC, Smithers BM, Menzies B, Branicki FJ, Rhodes M, Nathanson L.

Ann Acad Med Singapore. 1996 Sep;25(5):646-9.

PMID:
8923996

Supplemental Content

Loading ...
Support Center